Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Hemostatic Agents Market covering 2026–2035?

The hemostatic agents market size has demonstrated substantial growth in recent years. A rise is anticipated from $4.42 billion in 2025 to $4.66 billion by 2026, achieving a compound annual growth rate (CAGR) of 5.4%. This historical growth can be linked to a limited assortment of hemostatic agents, the dependence on traditional thrombin and gelatin products, an increase in surgical procedures, developing hospital infrastructure, and an increased awareness of blood loss management.

The hemostatic agents market size is anticipated to undergo substantial growth in the upcoming years. It is projected to reach $5.71 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%. The expansion during this forecast period is attributable to the development of recombinant and sprayable fibrin sealants, an increase in minimally invasive and orthopedic surgeries, a growing demand for multi-agent and combination hemostats, wider adoption in plastic and neurosurgery applications, and a regulatory focus on sterility and biocompatibility. Prominent trends within the forecast timeframe include a rising demand for advanced hemostatic agents in surgical procedures, the increasing utilization of combination and multi-agent hemostats, growth in fibrin sealants and biologically derived products, an expansion of hemostats use in trauma and cardiovascular surgeries, and an enhanced emphasis on safety, sterility, and regulatory compliance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Hemostatic Agents Market?

The future expansion of the hemostatic agents market is anticipated to be driven by the rising volume of surgical procedures. These procedures involve healthcare professionals performing medical operations with specialized tools to treat, mend, or excise bodily sections for health reasons. This surge in surgeries primarily stems from a growing incidence of chronic conditions, frequently necessitating surgical intervention to address health concerns and enhance patient recovery. During operations, hemostatic agents play a crucial role by rapidly stemming hemorrhage, thereby minimizing blood loss and enhancing surgical field clarity for precise execution. As an illustration, the UK Health Security Agency (UKHSA), a national government public health agency located in the UK, reported surveillance findings for the 2023–24 timeframe in October 2025. This data indicated that 135,619 operations were logged, with 1,276 surgical site infections (SSIs) identified either during hospitalization or upon re-admission, signifying an 8.4% increase in submissions compared to the preceding year. Consequently, the expanding volume of surgical procedures is a key factor propelling the growth of the hemostatic agents market.

What Segments Are Identified Within The Structure Of The Hemostatic Agents Market?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

What Trends Are Driving The Growth Trajectory Of The Hemostatic Agents Market?

Leading companies in the hemostatic agents market are concentrating on developing sophisticated solutions, such as collagen-based hemostats, to ensure swift and effective blood clotting and tissue sealing for both traditional and minimally invasive surgical procedures. These collagen-based hemostats are materials derived from purified collagen designed to help stop bleeding by enhancing the body’s natural coagulation process at the site of an injury or surgical incision. For example, in March 2025, Baxter, a US-based healthcare company, launched HEMOPATCH Sealing Hemostat, an absorbable pad utilizing collagen. This advanced collagen-based pad incorporates a dual-action system that combines a collagen matrix with an NHS-PEG layer, which forms a hydrogel upon contact with moisture, allowing for quick sealing of bleeding areas. It offers strong adhesion to wet tissues, making it suitable for both open and minimally invasive surgeries where other agents might be less effective. The patch provides hemostasis in under two minutes without requiring temperature-controlled storage or specific preparation, thereby streamlining surgical workflows. Additionally, it naturally dissolves in the body within 6 to 8 weeks and can be stored at room temperature for up to three years, addressing significant clinical and storage demands.

Which Leading Companies Dominate The Hemostatic Agents Market Share?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z‑Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

How Does The Hemostatic Agents Market Perform Across Major Global Regions?

North America was the largest region in the hemostatic agents market in 2025. The regions covered in the hemostatic agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hemostatic Agents Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2026, By The Business Research Company

Hemostats Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hematology Drug Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company